Secondary analysis of a cluster randomised trial in 31 paediatric practices: clinicians starting HPV vaccination at 9–10 vs 11–12 years reported no significant difference in parental concerns, pushback or hesitancy, and more often reported shorter discussions (55% vs 37%).
Secondary analysisn = 31 practices
Szilagyi et al. Clinician Perceptions of the Impact of Switching HPV Vaccine Initiation to 9-10 Years